✦ LIBER ✦

Relative efficiency and risk of endomyocardial biopsy: Comparisons in heart transplant and nontransplant patients

✍ Scribed by Anastasiou-Nana, Maria I. ;O'Connell, John B. ;Nanas, John N. ;Sorensen, Sherman G. ;Anderson, Jeffrey L.

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 450 KB
Volume: 18
Category: Article
ISSN: 0098-6569
DOI: 10.1002/ccd.1810180103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measurement of adenylate cyclase activit

Measurement of adenylate cyclase activity in the right ventricular endomyocardial biopsy samples from patients with chronic congestive heart failure

✍ Atsushi Sugiyama; Tetsuro Shirai; Kiyoshi Inoue; Keith G. Lurie; Keitaro Hashimo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

Cyclophosphamide plus dexamethasone is a

Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma : Results of a randomized comparison with vincristine, doxorubicin, and dexamethasone

✍ Ulf-Henrik Mellqvist; Stig Lenhoff; Hans E. Johnsen; Martin Hjorth; Erik Holmber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract ## BACKGROUND Today, intensive therapy that includes high‐dose melphalan with autologous stem cell transplantation (ASCT) is considered standard therapy in younger patients with newly diagnosed myeloma. When the current trial was initiated, combined vincristine, doxorubicin, and dexame